Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland News Journal.

Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
REYKJAVIK, Iceland, May 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial...

BJMINING Unleashes AI-Powered Energy Arbitrage to Revolutionize Bitcoin Mining Profitability
London, July 06, 2025 (GLOBE NEWSWIRE) -- With Bitcoin currently trading at $107,000 — up 60% year-to-date—many U.S.-based mining operations are facing existential threats as single-coin production costs soar to $137,000. In stark contrast,...

Block Listing Six Monthly Return and Holding(s) in Company
Reykjavík, April 23, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company”) Block Listing Six Monthly Return and Notification of Major Holdings TORONTO, ONTARIO – 23 April 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an...

Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, RUSSIA,...

Marabu Airlines Teams Up with Plan3 to Enhance Passenger Care and Optionality During Disruptions
A New Era of Passenger-Centric Disruption Management with Scalable, Digital Solutions REYKJAVIK, 105, ICELAND, April 30, 2025 /EINPresswire.com/ -- The impact of airline IROPS on the passenger experience has long been challenging to resolve,...

Holding(s) in Company
Reykjavík, April 14, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") Total Voting Rights and Notifications of Major Holdings TORONTO, ONTARIO – 14 April 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an independent mining...

Lucinity and Creditinfo Partner to Integrate PEP Screening Seamlessly into AI Workflows
REYKJAVIK, Iceland , May 07, 2025 (GLOBE NEWSWIRE) -- Lucinity, a global leader in AI-driven compliance software, has partnered with Creditinfo, a trusted and leading provider of credit and risk intelligence solutions, to integrate access to...

Open Ocean Robotics Launches First USV for Marine CO₂ Removal Monitoring with Sales to Leading Research Institutions
With initial sales to Dalhousie University and Iceland’s Röst Centre, Open Ocean Robotics introduces first USV built for marine carbon removal monitoring. VICTORIA, BRITISH COLUMBIA, CANADA, May 9, 2025 /EINPresswire.com/ -- Open Ocean Robotics...

Lucinity Featured in Chartis Research FinCrime and Compliance 50 Ranking for 2025
REYKJAVIK, Iceland, May 08, 2025 (GLOBE NEWSWIRE) -- Lucinity has been listed among the top 50 Financial Crime and Compliance (FCC) companies in the 2025 FCC50 ranking by Chartis Research. This recognition reflects Lucinity’s continued ability to...

Management Increasing Ownership in Amaroq Minerals and RSU Vesting Update
Reykjavík, April 09, 2025 (GLOBE NEWSWIRE) -- "Amaroq" or the "Company" Management increasing ownership in Amaroq Minerals And Vesting under the Restricted Share Unit Plan (the “RSU Plan”) and PDMR purchases TORONTO, ONTARIO – 09 April 2025 –...

Holding(s) in Company
Reykjavík, April 07, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer...

Holding(s) in Company
Reykjavík, April 01, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer...

2024 Full Year Financial Results
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") 2024 Full Year Financial Results 2024 - a pivotal year marking the transition from developer to producer at our flagship Nalunaq mine TORONTO, ONTARIO – 28 March 2025 –...

Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs The agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab)...

Holding(s) in Company
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer...

Significant Increase in Nalunaq Mineral Resource Estimate
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Significant Increase in Nalunaq Mineral Resource Estimate **51% Growth in Contained Gold and Inclusion of Maiden Indicated Resources** TORONTO, ONTARIO...

Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...

UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
REYKJAVIK, Iceland, PISCATAWAY, N.J. and LONDON, March 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition...

Notice of Results and Investor Presentation
Reykjavík, March 21, 2025 (GLOBE NEWSWIRE) -- (“Amaroq Minerals” or the “Company”) Notice of Results and Investor Presentation TORONTO, ONTARIO – 21 March 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine...